Published • loading... • Updated
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Summary by Bioethics.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
(Ars Technica) – The global health organization Coalition for Epidemic Preparedness Innovations (CEPI) announced Monday that it will “urgently accelerate development” of three vaccine candidates against Bundibugyo ebolavirus (BDBV), pledging a little over $60 million in the effort to extinguish an outbreak currently raging out of control in the Democratic Republic of the Congo. Under the plans, CEPI has committed up to $50 million to US-based Mo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
